eXoZymes, Inc

EXOZNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

9.28M

on 2026-06-30, from 6.25M on 2024-09-30 10-Q ↗

a raise that quarter, at its price

Newest

$50.0M

S-3 of 2026-01-16. 2 prospectus supplements filed under it since. S-3 ↗

None

No at-the-market programme on file in the last 30 months.

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

3.2 quarters

$5.7M on 2026-06-30 ÷ $1.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-30	Public offering	71,110	not read	$640K	424B5 ↗
2026-06-05	Public offering	592,270	not read	$5.3M	424B5 ↗
2024-11-18	Private placement	93,750	not read	$12K	8-K ↗
2024-11-11	Public offering with warrants at $8.00	1,875,000	$8.00	$15.0M	424B4 ↗